Pinnacle Wealth Planning Services, Inc.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1726752 MANSFIELD, OH

Back to BCRX Full portfolio

Position in BCRX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$121,646

+$21,978 QoQ

Shares Held

12,778

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Pinnacle Wealth Planning Services, Inc. holds $2,221,462 across 32 Drug Manufacturers - Specialty & Generic names. BCRX ranks #7 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	12,946	$389,933
2	RDY	Dr Reddys Laboratories Ltd	24,068	$333,341
3	ELAN	Elanco Animal Health Inc	10,366	$248,058
4	ZTS	Zoetis Inc.	1,385	$163,720
5	SUPN	Supernus Pharmaceuticals, Inc.	3,107	$160,600
6	TAK	Takeda Pharmaceutical Co Ltd	6,596	$122,157
7	BCRX	Biocryst Pharmaceuticals Inc This page	12,778	$121,646
8	HLN	Haleon plc	12,004	$120,160

All Filings in BCRX

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$121,646	12,778	0.0%	Shares	Sole	2026-05-11
2025-12-31	$99,668	12,778	0.0%	Shares	Sole	2026-02-13
2025-09-30	$96,985	12,778	-24.7%	Shares	Sole	2025-11-13
2025-06-30	$151,979	16,962	+31.3%	Shares	Sole	2025-08-11
2025-03-31	$96,855	12,914	+1.6%	Shares	Sole	2025-05-15
2024-12-31	$95,579	12,710	-48.6%	Shares	Sole	2025-02-27
2024-09-30	$188,054	24,744	+7.4%	Shares	Sole	2024-11-13
2024-06-30	$142,362	23,036	+12.0%	Shares	Sole	2024-08-09
2023-12-31	$123,160	20,561	+14278.3%	Shares	Sole	2024-02-08
2020-12-31	$1,065	143	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.